SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-274925
Filing Date
2020-10-23
Accepted
2020-10-23 08:09:02
Documents
12
Period of Report
2020-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d92101d8k.htm   iXBRL 8-K 44578
  Complete submission text file 0001193125-20-274925.txt   176535

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sldb-20201022.xsd EX-101.SCH 3070
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20201022_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20201022_pre.xml EX-101.PRE 11860
5 EXTRACTED XBRL INSTANCE DOCUMENT d92101d8k_htm.xml XML 3475
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 201256058
SIC: 2836 Biological Products, (No Diagnostic Substances)